Health

GHNHSFT - Redirect, Health

Dear Sir/Madam,

This is a Freedom of Information request.

1. Please can you tell me if your Trust has ever piloted, or used, electronic monitoring tags to facilitate leave for patients who have been detained under the mental health act?

2. If you have, please can you tell me if you have ever evaluated or audited the use of such tags?

I understand you will acknowledge my request and aim to respond within 20 working days, which I make by the 11th July.

Thank you for your assistance

Yours sincerely,

Bone cancer long-term follow-up and late effects services details

Dear Sir/Madam,

Under the Freedom of Information Act 2000, please provide the following information about long-term follow-up and late effects services available to patients within your organisation who have been treated for primary bone cancer (bone sarcoma).

This Freedom of Information (FOI) request is part of a UK-wide service mapping exercise examining national long-term follow-up and late effects services for patients and survivors of primary bone cancer. This study has ethical approval and is led by researchers at the University of Bath and the Bone Cancer Research Trust (BCRT).

We are seeking information that is already recorded and held by your organisation. If the requested information is not held, please indicate this in your response.

To support an accurate and comprehensive response, we kindly ask that this request is reviewed by, or forwarded to, the most appropriate services within your organisation. This may include sarcoma services, as well as paediatric, teenage and young adult (TYA), and adult teams involved in the care of patients with primary bone cancer (for example, oncology, orthopaedic surgery, radiotherapy, bone tumour or surveillance clinics, allied health professionals, endocrinologists etc and any dedicated late effects services).

Responses to this FOI will contribute to a detailed and comprehensive overview of current service provision. This will support our aim to better inform patients and families about the support available to them, as well as to identify any gaps or disparities in access and provision.

Please find below definitions of long-term follow-up and late effects services for the purposes of this FOI. We recognise that the terms “long-term follow-up” and “late effects service” are sometimes used interchangeably, and their application may vary between organisations.

Long-term follow-up: Long-term follow-up describes the ongoing clinical reviews required after completion of cancer treatment. Initially, these reviews may include surveillance investigations (e.g. imaging). Over time, once a period of clinical stability is reached, routine imaging may cease; however, follow-up continues. Long-term follow-up includes monitoring for potential late effects of treatment and the management of any issues that arise as a result.

Late effects service: A late effects service focuses on the assessment and management of health problems that occur months or years after treatment, including those related to surgery, chemotherapy, or radiotherapy. This may be delivered as a distinct service, or as part of a broader long-term follow-up service.
Late effects monitoring service: A late effects monitoring service provides structured, ongoing surveillance for potential late effects following cancer treatment. This typically involves regular, scheduled reviews and may include investigations (e.g. imaging, blood tests, or functional assessments) to identify late effects early, even in the absence of symptoms.

1. Please provide details of the region your NHS Trust/Health Board represent:

2. Does your Trust/Health Board currently provide, host, or commission any service(s) that deliver long-term follow-up and/or late effects care for patients previously treated for primary bone cancer?

Yes or No

3. If yes, please provide details of the service:

Service name:
Service location:
Website (if available):
This service is best described as a (please indicate):

i. Long-term follow-up service

ii. Late effects service

iii. Late effects monitoring service

iv. Combined long-term and late effects service v. No service provided vi. Other (please specify) vii. Don’t know

4. Please fill in further details of the service:

a. Referral pathway(s) into service:

b. Age eligibility:

i. Upper age limit:

ii. Lower age limit:

iii. Or no age restrictions apply

iv. Don’t know

c. Geographical radius/catchment area where patients can access service:

5. Please specify which patient groups are eligible to access this service (please indicate all that apply):

a. Paediatric

b. Teenage and Young Adult (TYA)

c. Adults

d. Don’t know

6. Which treatment intent does this service support?

a. Radical or curative treatment only

b. Palliative treatment only

c. Both radical and palliative treatment d. Don’t know

7. Does your Trust/Health Board permit follow up contact from the research team solely for the purpose of clarifying information provided in this Freedom of Information response?

Yes or No

8. If yes, please provide preferred follow-up contact details:

9. Does your Trust/Health Board permit the information provided in this request to be used to inform patients about the availability of your long term follow up and/or late effects service for bone cancer survivors? (Information may be shared publicly for patient signposting and awareness purposes via the Bone Cancer Research Trust website).

Yes or No

Thank you for your time and support. We appreciate your assistance in helping us build an accurate picture of long-term follow-up and late effects service provision across the UK for bone cancer patients and survivors.

Kind regards,

Gloucestershire Adult Autism and ADHD Service Policies

CAMHS Services, Copy of Trust Policy, Health, MH Services

Under the Freedom of Information Act, I would like to request the following information:

1. All policy documents in respect of Gloucestershire Adult Autism and ADHD Service’s non-recognition of private diagnoses in respect of ADHD and autism assessments, which were relevant in the period 1 January 2021 to date.

2. All equalities and diversity assessments conducted in respect of the policy documents in point 1.

3. All supporting documents referred to in the policy documents and assessments in points 1 and 2.

4. Any internal discussion documents or minutes regarding potential changes to the policy documents and assessments in points 1 and 2.

I would like you to provide the information in electronic documents by email to the above address. If some documents will take longer to obtain, I should be grateful if you would provide an interim response with the documents that are available at that time.

Please contact me at the above email address if you need to clarify.

Use of AI in NHS Talking Therapy

Health, IT, MH Services

Dear Gloucestershire Health and Care NHS Foundation Trust,

Under the Freedom of Information Act, I would like to request the following information:

1. Is this NHS Trust utilizing an AI software within its Talking Therapy Programme? In what capacity?
2. The number of patients who have been treated under a scheme of therapy that involves a communication exchange including the contribution of an Artificial Intelligence system in 2025 and 2026.
3. Please break down the number of users into the following classes: i) age, ii) ethnicity, iii) nationality, iv) gender.
If the numbers are less than 5, please merge the figures for 2025 and 2026.
4. The name of the company providing the AI software(s) mentioned in 1 and 2. Please also tell me the name of the system (ex. ChatGPT, Claude, etc).
5. The value of the contract between the AI company and the NHS trust.
6. Investigations, reports and other similar documents thar look into: :
a. the clinical effectiveness of therapy undergone by patients using the therapy mentioned in 1 and 2 above,
b. any potential risks from the therapy mentioned in 1 and 2 above.

7. The current waiting list for an appointment with a therapist within your NHS Talking Therapy service.
8. The current waiting list for an appointment with a psychiatrist.

I would like you to provide the information in the following format:

Word or Excel file.

Please contact me if you need me to clarify my request.

Yours faithfully,

Homelessness and Duty to Refer

Dear FOI Officer,

I am writing on behalf of Homelessness Best Practice. Under the Freedom of Information Act 2000, I am writing to request the following information for your trust:

1. Hospital Inpatients Identified as Homeless
a. The total number of patients identified as experiencing homelessness while admitted to hospital during the period 1 January 2025 – 31 December 2025.
b. If possible, please provide a breakdown by month.
c. If homelessness is recorded in your patient record system, please indicate the field name or coding used (e.g., “No Fixed Abode”, “Housing Status”, “Domestic Abuse” etc).

2. Duty to Refer Referrals
a. The total number of Duty to Refer referrals made to local housing authorities for patients identified as homeless during the same period 1 January 2025 – 31 December 2025.
b. If available, please provide a breakdown by month.

3. Service or Policy Data
a. Does the trust have a dedicated homelessness liaison nurse, social worker, or specialist team?
b. Are there formal policies or procedures for identifying homelessness on admission and throughout treatment?
c. What training does the trust provide for staff on:
i. Identifying homelessness
ii. The Duty to Refer under the Homelessness Reduction Act 2017?
d. If available, please provide any written guidance, protocols, or discharge guidance given to staff to support patients experiencing homelessness.

If any of this information is publicly available, please provide the relevant links.

Please provide the information in electronic format (Excel, CSV, or PDF) where possible. If any part of this request is unclear, or if certain data cannot be provided, please advise on exemptions or alternatives. I would be grateful for a response within the statutory 20 working days.

Thank you for your assistance.

Kind regards,

Homelessness and Duty to Refer

Dear FOI Officer,

I am writing on behalf of Homelessness Best Practice CIC and Expert Citizens CIC. Under the Freedom of Information Act 2000, I am writing to request the following information for your trust:

Hospital Inpatients Identified as Homeless

1. The total number of patients identified as experiencing homelessness while admitted to hospital during the period 1 January 2025 – 31 December 2025.
2. If possible, please provide a breakdown by month.
3. If homelessness is recorded in your patient record system, please indicate the field name or coding used (e.g., “No Fixed Abode”, “Housing Status”, “Domestic Abuse” etc).

Duty to Refer Referrals

1. The total number of Duty to Refer referrals made to local housing authorities for patients identified as homeless during the same period 1 January 2025 – 31 December 2025.
2. If available, please provide a breakdown by month.

Service or Policy Data

1. Does the trust have a dedicated homelessness liaison nurse, social worker, or specialist team?
2. Are there formal policies or procedures for identifying homelessness on admission and throughout treatment?
3. What training does the trust provide for staff on:

a. Identifying homelessness
b. The Duty to Refer under the Homelessness Reduction Act 2017?

4. If available, please provide any written guidance, protocols, or discharge guidance given to staff to support patients experiencing homelessness.

If any of this information is publicly available, please provide the relevant links.

Thank you for your assistance.

Kind regards,

Councelling Offered to Patients

Hi,

I hope this is the appropriate place to direct this query to, please let me know if not, and thank you in advance for your support with this.

I’m currently a trainee counsellor and part of my level 5 course is a research project. My proposed topic is on the number of counselling sessions offered to patients by organisations to see if there is any consistency in the offer and how many sessions is ideal for patients. In light of this, could you please let me know the answers to the following questions?

Does your organisation currently provide counselling services to patients? (If no, please don’t worry about the remaining questions!)

How many counselling sessions are made available for patients?

Are patients/counsellors given the option to extend the number of sessions if required? If so, is there a maximum number of sessions?

What rationale was used to set the number of sessions offered to patients?

Is there any written reports or guidance that you used to support the decision? If yes, which?

Thank you for taking the time to read this email, I look forwards to hearing back from you.

Many thanks,

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Dear Gloucestershire Health and Care NHS Foundation Trust,

I would appreciate your input on the following questions

1. Service Context & Care Pathway

• Does your Trust diagnose and/or treat patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)?

Our response:

You asked:

• If yes, which clinical departments or specialties are responsible for CIDP diagnosis and management?
(e.g., Neurology, Neurophysiology, Immunology, Specialist Neuromuscular Services)
• Does your Trust operate a specialist neuromuscular or neuroimmunology service?
If so, please provide a brief description (e.g., staffing, catchment area, referral pathways).

2. CIDP Patient Numbers
• How many patients with a confirmed diagnosis of CIDP are currently recorded within your Trust?
Please provide the most recent 12 month period available.
• If available, please provide the number of newly diagnosed CIDP patients in the same period.
• If diagnosis data are coded, please confirm which coding system is used (e.g., ICD 10, SNOMED CT).

3. CIDP Treatment With IVIg
• How many CIDP patients received intravenous immunoglobulin (IVIg) at your Trust in the most recent 12 month period?
• Please provide the number of IVIg treatment episodes administered to CIDP patients in that period.
• If available, please provide the total volume (grams) of IVIg used for CIDP during the same period.
• How many CIDP patients received IVIg vs SCIg in the most recent 12‑month period?
• If SCIg is used, please provide the number of treatment episodes and total grams administered.
• If available, please provide typical dosing regimens used for CIDP (e.g., grams/kg and treatment intervals).
• If recorded, please provide the average number of IVIg cycles per CIDP patient per year.

4. Operational & Capacity Information
• Does your Trust have a formal protocol or clinical guideline for the diagnosis and management of CIDP?
If yes, please provide a copy or link.
• Does your Trust operate a waiting list for IVIg treatment?
If yes, please provide the current number of patients waiting and the average waiting time.
• Does your Trust participate in any regional or national neuromuscular networks relevant to CIDP?
• Does your Trust record adverse events or complications associated with IVIg administration in CIDP patients? If yes, please provide any available summary data.

5. Commissioning, Governance & Funding
• Which commissioning arrangements apply to CIDP treatment at your Trust?
(e.g., specialised commissioning, local ICB commissioning)
• Does your Trust use a prior approval or funding request process for IVIg in CIDP?
• Does your Trust participate in the National Immunoglobulin Database (NID)? If yes, do you routinely submit CIDP specific data?

Thank you in advance
Yours faithfully,

Electro Convulsive Treatment/Restraints/Seclusion/Medicated Errors

Hello
Hope you are good + thank you for all you do …
Please could you answer the following questions under the freedom of information act ….
If you would like to split the request into 4 parts – please do so …
I am dyslexic – so please provide the data in email text – which is one of my preferred formats
Hope we have a good week
In love + solidarity

Please provide Electro Convulsive Treatment (ECT) information under the FOI act to the following questions: –
1.Please supply patient’s information ECT leaflet
2.Please supply patient ECT consent form
3.Please supply any ECT reports/investigations
4.How many ECT in 2025?
5.What proportion of patients were men/women?
6.How old were they?
7.What proportion of patients were classified people of the global majority or racialised communities (“POC / BAME”)?
8.How many people covered by the equality act – specific protected characteristics – excluding age + gender – received ECT ?
9.How many people were offered talking therapy prior to ECT ?
10.How many were receiving ECT for the first time?
11.How many patients consented to ECT?
12.How many ECT complaints were investigated outside the NHS ?
13.How many patients died during or 1 month after ECT and what was the cause (whether or not ECT was considered the cause)?
14.How many patients died within 6 months after ECT and what was the cause (whether or not ECT was considered the cause)?
15.How many patients died by suicide within 6 months of receiving ECT (whether or not ECT was considered the cause)?
16.How many patients have suffered complications during and after ECT and what were those complications?
17.Have there been any formal complaints from patients/relatives about ECT?
18.If so, what was their concerns?
19.How many patients report memory loss/loss of cognitive function?
20.What tests are used to assess memory loss/loss of cognitive function?
21.Have MRI or CT scans been used before and after ECT?
22.If so, what was the conclusion?
23.How does the Trust plan to prevent ECT in the future?

Please provide restraints information under the FOI act to the following questions: –
1.Please supply any Restraints/investigations
2.How many RESTRAINTS in 2025?
3.What proportion of patients were men/women?
4.How old were they?
5.What proportion of patients were classified people of the global majority or racialised communities (“POC / BAME”)?
6.How many people covered by the equality act – specific protected characteristics – excluding age + gender – were restrainted?
7.How many RESTRAINTS were investigated outside the NHS?
8.How many patients died during or 1 month after RESTRAINTS and what was the cause (whether or not RESTRAINTS was considered the cause)?
9.How many patients died within 6 months after RESTRAINTS and what was the cause (whether or not RESTRAINTS was considered the cause)?
10.How many patients died by suicide within 6 months of receiving RESTRAINTS (whether or not RESTRAINTS was considered the cause)?
11.How many patients have suffered complications during and after RESTRAINTS and what were those complications?
12.Have there been any formal complaints from patients/relatives about RESTRAINTS?
13.If so, what was their concerns?
14.Are counts of forced injections available? if so how many people were forcible injected ?
15.How does the Trust plan to reduce restraints in the future?
16.How many of these restraints were face down restraints?

Please provide SECLUSION information under the FOI act to the following questions: –
1.Please supply any SECLUSION reports/investigations
2.How many SECLUSIONS in 2025?
3.What proportion of patients were men/women?
4.How old were they?
5.What proportion of patients were classified people of the global majority or racialised communities (“POC / BAME”)?
6.How many people covered by the equality act – specific protected characteristics – excluding age + gender – were secluded ?
7.How many SECLUSIONS were investigated outside the NHS?
8.How many patients died during or 1 month after SECLUSION and what was the cause (whether or not SECLUSION was considered the cause)?
9.How many patients died within 6 months after SECLUSION and what was the cause (whether or not SECLUSION was considered the cause)?
10.How many patients died by suicide within 6 months of receiving SECLUSION (whether or not SECLUSION was considered the cause)?
11.How many patients have suffered complications during and after SECLUSION and what were those complications?
12.Have there been any formal complaints from patients/relatives about SECLUSION?
13.If so, what was their concerns?
14.How does the Trust plan to reduce SECLUSIONS in the future?

Please provide MEDICATION ERRORS information under the FOI act to the following questions: –
1.Please supply any MEDICATION ERRORS reports/investigations
2.How many MEDICATION ERRORS in 2025?
3.What proportion of patients were men/women?
4.How old were they?
5.What proportion of patients were classified people of the global majority or racialised communities (“POC / BAME”)?
6.How many people covered by the equality act – specific protected characteristics – excluding age + gender – endured medication errors ?
7.How many MEDICATION ERRORS were investigated outside the NHS ?
8.How many patients died during or 1 month after MEDICATION ERRORS and what was the cause (whether or not MEDICATION ERRORS was considered the cause)?
9.How many patients died within 6 months after MEDICATION ERRORS and what was the cause (whether or not MEDICATION ERRORS was considered the cause)?
10.How many patients died by suicide within 6 months of receiving MEDICATION ERRORS (whether or not MEDICATION ERRORS was considered the cause)?
11.How many patients have suffered complications during and after MEDICATION ERRORS and what were those complications?
12.Have there been any formal complaints from patients/relatives about MEDICATION ERRORS?
13.If so, what was their concerns?
14.How does the Trust plan to prevent MEDICATION ERRORS in the future?

Neurodiversity Services (ADHD and ASD)

Clinical Activity Data, Health, MH Services

Dear FOI Team, I am investigating NHS-commissioned Neurodiversity Services (ADHD and ASD) across the UK. “Neurodiversity Services” here includes assessment, medication initiation / titration and post-diagnostic support to individuals in the community. In England, this includes provision delivered via Right to Choose / Any Qualified Provider arrangements, where applicable. Under the Freedom of Information Act 2000, I would like to request the following information: 1. Please provide your total annual spend (for each of the last three financial years, FY23/24, FY24/25, FY25/FY26) on ADHD and Autism assessments, broken down by: a. Total annual spend by third party private provider* b. For each third party private provider, total annual spend by assessment type (ADHD / Autism) 2. Please provide your total number of patients (for each of the last three financial years, FY23/24, FY24/25, FY25/FY26) on ADHD and Autism assessments, broken down by: a. Total number of patients assessed by third party private provider* b. For each third party private provider, total number of patients assessed by assessment type (ADHD / Autism) 3. For each third party private provider, please indicate the contract type (block / activity-based), start date and end date Please include volumes from NHS Trusts within your ICB that may deliver these services, and also third party private providers (or indicate if this is not possible) FY is defined as a year starting in April and ending in March. For example, FY23/24 starts on 1 April 2023 and ends on 31 March 2024. If exact spend by provider is not disclosable, please provide spend in bands (e.g., £5m) or top 5 providers plus ‘all others’ *Third-party private providers Refers to independent, non-NHS organisations contracted to deliver ADHD and / or Autism services. These providers operate outside of NHS Trusts / ICBs / Health Boards and typically deliver services such as assessments, prescribing, post-diagnostic support, and therapy. Examples may include (but are not limited to) ADHD 360, Psychiatry UK, Clinical Partners, and Evolve Psychology. These providers may deliver services under direct contracts with the ICB, via framework agreements, or under the NHS Right to Choose pathway. Best regards, Rosie Seel

Young Onset Dementia

Dear Sir/Madam,
I am writing to request information under the Freedom of Information Act 2000 regarding individuals with young onset dementia (defined as individuals of any age who first experienced symptoms of dementia under the age of 65 and then received a formal diagnosis) within your local authority area.
Please provide the following information, using the most recent available data (preferably as of 14 April 2026 where possible).
Where data specific to young onset dementia as defined above is not held, please provide the closest available proxy (for example, individuals under 65 with a dementia diagnosis and note the proxy that has been used).
Questions
• The number of individuals who were diagnosed with dementia under the age of 65 currently under the care of your services.
• The number of individuals under the age of 65 diagnosed with dementia within the most recent 12 months of validated data.
• The number of individuals who were under the age of 65 when diagnosed with dementia who were detained under the Mental Health Act in the last 12 months (if recorded).
• The number of individuals who were diagnosed with dementia under the age of 65 currently receiving Section 117 aftercare (if recorded).
• The number of individuals who were diagnosed with dementia under the age of 65 currently:
o Receiving community-based support
o Admitted to inpatient mental health settings
• The number of individuals under the age of 65 with dementia who have experienced a delayed discharge from inpatient settings in the last 12 months (if recorded).
• Does your organisation routinely record young onset dementia as a distinct category within its data systems? (Yes/No)
If the requested information is not held in the exact format above, please provide the closest available data.
If any part of this request exceeds cost limits, please provide advice and assistance to refine the request.

Please let me know if you have any questions.
Kind regards,

Urgent & Emergency Services Provided – Young people who Self Harm

To whom it may concern,

This is a request under the Freedom of Information Act 2000.

I am seeking information about urgent and emergency services provided by your organisation for young people following self-harm.

Please could you provide the following information?

1. A list of all services/pilots/programmes provided by your organisation that offer support, assessment or intervention to young people (aged 25 years or under) within 24 hours of a self-harm episode (defined according to NICE 2022: intentional self-poisoning or injury, irrespective of the apparent purpose).

2. For each service identified, please provide (where available):

a. Service name
b. Brief description of the service (e.g., aim and objectives)
c. Eligibility criteria (including age)
d. Access routes (e.g., telephone, walk-in service, referral from A & E/GP)
e. Service setting (e.g., online, community-based, hospital-based)
f. Availability (days and hours of operation) g. Geographic area covered

I am specifically interested in services that respond within 24 hours of a self-harm episode, instead of longer-term or routine care (eligible services may include crisis teams, liaison psychiatry services, safe havens, crisis cafes, helplines and other urgent mental health support services). For the avoidance of doubt,

I am looking for any services for individuals aged 25 years or under, including both specialist children/young people’s services and services primarily designed for adults that may also be accessed by this age group.

Thank you in advance for your time and assistance.

Kind regards

Patient Bedside Entertainment Systems

Dear Freedom of Information Team,

Please provide the following information under the Freedom of Information Act 2000 in relation to patient bedside entertainment and engagement systems within your Trust.

Where possible, please provide the most recent available information.

1. Bed Capacity

a) What is the total number of inpatient beds across the Trust?

2. Bedside Entertainment Provision

a) How many inpatient beds are equipped with bedside entertainment systems?
b) If possible, please indicate the approximate proportion of total beds this represents.

3. Provider Information

a) Who is the current provider (or providers) of bedside entertainment services?
b) If services vary by site or ward, please provide details where available.

4. Contract Details

a) What is the start date of the current contract(s)?
b) What is the end or renewal date of the contract(s)?
c) If applicable, what is the total contract value or annual cost?

5. Patient Access via Personal Devices (BYOD)

a) Does the Trust provide access to entertainment or digital services via patients’ personal devices?
b) If yes, please briefly describe the services available.

6. Services Offered

a) What services are provided through bedside systems (e.g.
television, radio, internet access, patient education, communication tools)?
b) Please indicate which of these are currently active.

7. Usage and Engagement

a) Does the Trust collect usage or engagement data for these systems?
b) If yes, please provide any available summary metrics (e.g. number of users, sessions, or usage rates).

8. Patient Feedback

a) Does the Trust collect patient satisfaction or feedback relating to bedside entertainment systems?
b) If yes, please provide any available summaries or key findings.

9. Support Model

a) Is the bedside entertainment system supported internally or by an external provider?
b) If externally supported, please confirm the provider responsible.

If any part of this request exceeds cost limits, please provide the information up to the limit and advise how the request may be refined.

If the information is already publicly available, please provide a link.

Please provide the response in electronic format.

ATTR Referrals

Dear Gloucestershire Health and Care NHS Foundation Trust,

For the most recent three complete calendar years (e.g. 2023, 2024 and 2025), please provide:

1. The number of patients your Trust referred onwards with a suspected or confirmed diagnosis of transthyretin amyloidosis (ATTR).

If possible, please break this down by:

• Year
• Referring specialty (e.g. cardiology, neurology, nephrology)

2. For the same period, please specify:

• The external centre(s) to which patients with suspected or confirmed ATTR amyloidosis were referred (e.g. National Amyloidosis Centre, regional amyloidosis hubs, tertiary cardiology centres).

Where available, please include:

• The number of patients referred to each centre per year.

Yours faithfully,

Use of non-visual patient safety aid (NVPSA)

Dear Gloucestershire Health and Care NHS Foundation Trust,

I am writing to make a request for information under the Freedom of Information Act 2000 regarding the Trust’s use of specific patient monitoring technology.

1. Does the Trust currently use, or have formal plans to trial or implement, a Non-Visual Patient Safety Aid (NVPSA) – for example, Safehinge Primera’s “Project X”, “Smart Ward” or other radar-based motion tracking – within ward bedrooms, Section 136 suites, and/or seclusion rooms?

2. If the response to the above question is ‘yes’, please provide the following information:

2.1. The number of wards, 136 suites, and seclusion rooms where the technology is deployed (please provide ward names and type of ward).

2.2. The current Policy or Standard Operating Procedure (SOP) governing the use of this technology, including details of your consent process.

2.3. The Data Protection Impact Assessment (DPIA).

2.4. The Equality Impact Assessment (EqIA).

2.5. The Clinical Safety Case Report and Clinical Hazard Log (as required by DCB0129/DCB0160 standards). Please also provide a copy of any entries on the Trust’s Organisational Risk Register that relate to “transferred risks” or residual risks identified during the deployment of this technology.

2.6. The contract start and end dates for the current provision.

2.7. Minutes of meetings where the decision to adopt, trial, continue, expand, or cease the use of the technology was made, including the rationale for the decision.

2.8. Copies of patient-facing information, such as posters, leaflets, or privacy notices provided to service users and carers.

2.9. Copies of all staff training materials or presentation slides relating to the use of NVPSA, including details of the Trust’s competency assurance framework, the mandated frequency of refresher training and the compliance rate (percentage of staff on the relevant wards who have completed training).

3. Please provide all recorded information relating to regulatory compliance, including:

3.1. Any internal audit, gap analysis, or briefing paper that demonstrates how the use of NVPSA technology complies with the Care Quality Commission (CQC) published guide on “Digital contactless patient monitoring technologies in mental health in-patient services”.

3.2. Evidence (e.g. a compliance statement or committee minute) showing how the deployment of this monitoring technology aligns with the NHS England’s “Principles for using digital technologies in mental health inpatient treatment and care”.

If you feel a Section 40 (Personal Information) or Section 43 (Commercial Interests) exemption applies to any part of this request, please provide a redacted version of the documents rather than a blanket refusal, and include the required public interest test for any qualified exemptions.

Yours faithfully,

Complex Home Care

Copy of Trust Policy, Health, MH Services

Under the Freedom of Information Act, I would like to request the following information relating to patients requiring complex home care packages on discharge from hospital.

For clarity, “complex home care” refers to high-acuity packages requiring significant care input (e.g. ventilation, tracheostomy care, enteral feeding, or complex neurological support) that goes beyond basic domiciliary home care assistance.

Failing that definition, please define “complex home care” as any home care package eligible for funding under the NHS Continuing Healthcare (CHC) funding pathway.

Please note I have requested a breakdown of the data by age group. If data cannot be broken down by requested age bands, then please provide total figures across all age groups, adults aged 18+ and children aged 0-17.

If data for the full year 2025/26 is not yet available, then please provide the latest yearly snapshot data for 2025/26.

Where possible, please kindly include responses on the attached spreadsheet.

1. Please provide the name, telephone number and email address of the person responsible for coordinating / liaising discharge from hospital to community health and social care providers.

2. For each of the following years (2022/23, 2023/24, 2024/25, and latest 2025/26 data), please provide the total number of bed days lost due to delays in arranging CHC-funded complex home care packages across:
a. All age patients
b. Adult patients aged 18-64 years
c. Child patients aged 0-17 years

3. Please provide the most recent available snapshot (e.g. March 2026) of the total number of patients currently in hospital who are medically fit for discharge but are awaiting a CHC-funded complex home care package across:
a. All age patients
b. Adult patients aged 18-64 years
c. Child patients aged 0-17 years

4. If available, please also provide latest equivalent snapshots for prior years (e.g. March 2025, March 2024, March 2023) of the total number of patients currently in hospital who are medically fit for discharge but are awaiting a CHC-funded complex home care package across:
a. All age patients
b. Adult patients aged 18-64 years
c. Child patients aged 0-17 years

5. For each of the following years (2022/23, 2023/24, 2024/25, and latest 2025/26 data), please provide the average time (in days) from being medically fit for discharge to discharge where a CHC-funded complex home care package is required across:
a. All age patients
b. Adult patients aged 18-64 years
c. Child patients aged 0-17 years

6. For each of the following years (2022/23, 2023/24, 2024/25, and latest 2025/26 data), please provide the number of patients who were assessed as requiring complex home care but were discharged to an alternative setting (e.g. residential or nursing care) due to a lack of CHC-funded complex home care packages across:
a. All age patients
b. Adult patients aged 18-64 years
c. Child patients aged 0-17 years
Kind regards,

Haemophilia A and B and von Willebrand Patients

Health, Pharmacy

Hi FOI team for Gloucestershire Health and Care NHS Foundation Trust,

Under the Freedom of Information (FOI) Act 2000 I would like to obtain the following information:

In Q1 2026 (January, February, March 2026), how many haemophilia A and B and von Willebrand patients were treated with the following coagulation factors in your trust and how much volume (IUs or mg) was used?

Brand name Number of treated patients Volume used (IUs, mg)
Hemlibra (non-inhibitor patients)
Hemgenix
Altuvoct
Advate
Adynovi
Elocta
Esperoct
NovoEight
ReFacto AF
Nuwiq
Hympavzi
Idelvion
Refixia
Alprolix
BeneFIX
Replenine
Rixubis
Veyvondi
Voncento
Wilate
Willfact

Best wishes,

Clinical Risk Assessment & Management and or Suicide Prevention

Hello Gloucestershire Health and Care NHS Trust FOI team,

I am writing to you under the Freedom of Information Act 2000 to request the following information from Gloucestershire Health and Care NHS Trust’s freedom of information department. Please may you provide me with:

1. A copy of your Policie(s)/ procedures, strategies and or any clinical guidance relevant to mental health care pertaining to clinical risk assessment and management and or suicide prevention.
2. Do you use any triage tools, rag rating or scales to stratify clinical risk?
2.1. If Yes, do they inform care in any way including different tiers.
2.2. If Yes please provide a copy.

Please provide the information in the form of word documents or if not possible pdf files.

If it is not possible to provide the information requested due to the information exceeding the cost of compliance limits identified in Section 12, please provide advice and assistance, under the Section 16 obligations of the Act, as to how I can refine my request.

If you can identify any ways that my request could be refined, I would be grateful for any further advice and assistance.

If you have any queries please don’t hesitate to contact me via email and I will be very happy to clarify what I am asking for and discuss the request, my details are outlined below.

Thank you for your time and I look forward to your response.

Best wishes,

Digital Mental Health

In accordance with the freedom of information act, please could you answer the following questions –

– Does the Trust commission or use any digital mental health and wellbeing platforms for its young people?

– Does the Trust mission or provide free access to digital mental health app for its young people?

– Which department, such as Public Health or Children’s Services, manages the commissioning of the digital services in this area?

– When does the current contract for this digital service with the Trust expire, and is it due to be recommissioned?

– Does the Trust provide access to any digital peer support services?

– Does the Trust provide access to any digital mental health services specifically for Autism?

– Does the Trust provide access to any digital mental health services specifically for those who are jobseekers?

Memory Assessment Services-Development & Transformation

Dear FOI Team,
I am writing to request information under the Freedom of Information Act (2000). Please provide the following information:
________________________________________
1. Request for attachments
1. Any local service models or pathway adaptations that influence capacity, demand, or access to imaging and biomarkers.

2. If available, please provide any SOPs, pathway diagrams, or service specifications (with personal data removed).

________________________________________
2. Activity and Demand for the last three natural years (2025, 2024, 2023)
1. Referral rate per 100,000 population of your memory clinic’s catchment area per year.

2. Referral routes (GP, internal mental health teams, acute trusts, self referral, other).

________________________________________
3. Waiting Times
Please provide mean and median waiting times (in 2023, 2024, 2025):
1. From referral to initial assessment.

2. From initial assessment to diagnosis of dementia (or conclusion of the assessment episode including formal diagnosis of MCI).

________________________________________
4. Diagnostic Process
1. Do non medical professionals conduct routine diagnostic initial assessments and do these require medical input in anyway?

2. Neuroimaging:
o Is a head scan carried out prior to initial assessments? (CT, MRI, PET modalities).

3. Biomarkers:
o Are any biomarkers (blood, CSF) available as a part of the diagnostic process?

________________________________________
5. Pharmacological Treatment and Post Diagnostic Support
1. Are non medical prescribers involved in routinely prescribing medication, and if they do, do they have to routinely confer with a medical professional?

________________________________________
6. Workforce and Assessment Model
1. Which of the roles listed below are exclusively dedicated to memory clinic work (PLEASE MARK WITH X):
Medical consultants
Non consultant doctors
B8 Nursing staff
B7 Nursing staff
B6 Nursing staff
B5 Nursing Staf
Occupational therapists
Clinical Psychology
Assistant Psychologist
Support workers / assistants
Administrative staff
Indicate for each non medical clinician whether they are non medical prescribers.

2. Number of yearly initial assessments (in 2025), separately for:
Medical Staff
Non-medical clinical staff

3. Could you provide information regarding the number of face-to-face and non-face-to-face contacts in 2025?

4. Is your team involved after the assessment and initiation of treatment in providing post diagnostic support, or is this provided by another provider? (VCSE etc.)

________________________________________
Format of Response
Please provide all data electronically, in Word, PDF or Excel format.

Discharges due to Missed Appointments

Hello,

On behalf of Sky News Communities team and in the public interest under the freedom of information act, please could you provide the following information:

1. Since February 2025 how many people has your trust discharged due to missed appointments?

2. Please can you also provide your trusts latest action plan for how your trust treats and engages with mental health patients? Please can you state the date this action plan was launched.

3. Please can you set out the latest plan on how your trust works with other agencies including the police? Please can you state the date this action plan was launched.

Thank you,

Additional Questions – 13 May 2026

Please could you confirm the data provided was for adult mental health patients only?

Please could you also advise when in 2025 the updated action plans were presented to the trust’s board?

Thank you

Liaison psychiatry services for Functional Neurological Disorder

Clinical Activity Data, Health, MH Services

Dear Freedom of Information Team, I am writing to request information under the Freedom of Information (FoI) Act 2000. This FoI request is part of a research study conducted by the University of Manchester. Our study aims to investigate the availability of liaison psychiatry services for patients presenting with a condition called Functional Neurological Disorder (FND). This current FoI request is to Gloucestershire Health and Care NHS Foundation Trust. We understand that there are liaison psychiatry teams at the sites detailed below. These questions would be best answered by the liaison psychiatry department themselves as there may be differences in practice between teams: Gloucestershire Royal Hospital Working Age Mental Health Liaison Service. If there are any liaison psychiatry teams we have missed out, please send this FoI request onto them. For further details about our study, please see our information sheet (attached) Our questions are available to answer on this Microsoft Form URL: {https://forms.office.com/Pages/ResponsePage.aspx?id=B8tSwU5hu0qBivA1z6kad3WY_jr6A6VJtgMzFzLptSlUMDc2SEtZTDFNTUdWVkU2N0VaWExSMUNUMi4u}

Should you not be able to access the Microsoft Form, the questions are detailed below:

FoI questions:

1. Does the liaison psychiatry service accept referrals for patients diagnosed with suspected or confirmed Functional Neurological Disorder (FND)?

a. No
b. Yes

2. Are there formal exclusion criteria that would prevent patients with FND from being assessed by liaison psychiatry?

a. No
b. Yes

i. What are the criteria?

3. Are there inclusion criteria within FND?

a. No
b. Yes

i. What are the criteria?

4. Where are patients with FND assessed?

a. Inpatient wards
b. Emergency departments
c. Outpatient settings
d. A mixture, please detail:
e. Not assessed at all

5. Is there a standardised assessment tool you use for patients with suspected or confirmed FND?

a. No
b. Yes

6. Do you have a policy, guideline or dedicated pathway for patients with suspected or confirmed FND?

a. No
b. Yes

7. Between January 2024-December 2025, how many patients with a suspected or confirmed FND were referred to liaison psychiatry? *

a.
b. Data not held

8. Between January 2024-December 2025, how many patients with a suspected or confirmed FND were accepted by liaison psychiatry? *

a.
b. Data not held

9. If FND patients are not seen by the liaison psychiatry team, are they referred to other services for assessment of their mental health?

10. Does the liaison psychiatry unit provide training to its staff on FND?

If yes, please specify.

a. No
b. Yes

i. Please specify:

11. Is your liaison psychiatry service commissioned to see patients with FND? * Alternative codes for FND: psychogenic, conversion, stress-induced, functional, pseudoseizure, dissociative, non-organic, psychosomatic, hysterical, psychological cause.

Mental Health Treatment Community and InPatient

Hi team,

I am writing to request the below information under the Freedom of Information Act 2000.

The number of young people (18-24 year olds inclusive) receiving mental health treatment- both community and inpatient.

The number of them who have been receiving treatment more than once (not their first time).

I would like the most recent figures you have available, and the same figures from January 2021.

Thank you,

Surgical Specialities

GHNHSFT - Redirect, Health

Dear FOI Team,

Please provide the following information for your Trust/hospital site(s) for the most recent complete 12-month period available (please state the exact start and end dates used).

If your data are only available at Trust level (not site level), please provide Trust-level figures and state this explicitly.

1) Surgical specialties in scope – Please report data separately for each of the following specialties (use the exact labels below):

1. Cardiothoracic Surgery
2. General Surgery (including: breast, colorectal, endocrine, upper GI, lower GI, and transplant—kidney, liver, pancreas)
3. Neurosurgery
4. Oral & Maxillofacial Surgery
5. ENT / Otolaryngology
6. Paediatric Surgery
7. Plastic Surgery
8. Trauma & Orthopaedic Surgery
9. Urology
10. Vascular Surgery

If a specialty is not provided at your Trust/hospital site(s), please record 0 for that specialty and note “not provided”.

2) Workforce (headcount) – For each specialty listed above, please provide:

• Number of Consultant surgeons (substantive/headcount)
• Number of SAS surgeons (headcount) (i.e., Specialty Doctor and Specialist grades)
Please provide headcount (not WTE). If you can only provide WTE, please state that clearly.

3) Population served – Please provide the total population served by your Trust/hospital (the figure you use for planning/catchment), and specify the source/definition used (e.g., “ICS population”, “catchment population”, etc.).

4) Surgical admissions activity -Please provide the total number of admissions (elective + emergency combined) to all surgical specialties in scope (i.e., the combined total across the 10 specialties listed above) for the same 12-month period.

If your admissions data are recorded using a different specialty grouping, please map as closely as possible and explain any assumptions.

Yours Sincerely

Use of Electroconvulsive Therapy (ECT)

Clinical Activity Data, Health, MH Services

Dear Sir/Madam,
I am writing under the Freedom of Information Act to make a request for information on the use of electroconvulsive therapy (ECT).
The information being requested is as follows:

1. Please provide the number of ECT treatments given to patients (if any) in the year 2025

2. Please provide the number of patients (if any) having received ECT treatment in the year 2025

I look forward to hearing from you in due course.

Yours faithfully,

Night-time In-Patient Care Implemented 24/25

Health, Staffing

Dear Gloucestershire Health and Care NHS Foundation Trust,

This request seeks information on practical service improvements in night-time inpatient care implemented during 2024/25, to support shared learning and benchmarking across NHS Trusts. The focus is on sleep, noise, and night-time disruption aligned with issues highlighted in the Care Quality Commission Adult Inpatient Survey.

Please answer for adult inpatient services

Night-time care and sleep
1. Night-time improvement initiatives
Please describe any Trust-wide or ward-level initiatives in place during 2024/2025 aimed at improving patients’ experience at night (e.g. reducing noise, improving sleep, reducing night-time disruption).

2. Policies or protocols
Does the Trust have any formal policy, protocol or guidance relating to:
o noise reduction at night,
o minimising non-urgent interventions overnight,
o minimising non-urgent ward moves during night hours?
If yes, please provide the title(s) and date(s).

3. Ward moves at night
During 2024/25, did the Trust take any specific actions to reduce non-urgent patient transfers or bed moves overnight (for example after 11pm)?
If yes, please describe the actions taken.

4. Staff training and awareness
Has the Trust delivered any training, briefings or awareness campaigns during 2024/25 relating to night-time care, sleep, noise reduction?
If yes, please describe.

5. Measuring impact
Please indicate which of the following are used to assess night-time care experience:
o National Inpatient Survey sleep/noise questions
o real-time patient feedback
o complaints or PALS themes
o local audits or ward observations
(Please specify all that apply.)

Yours faithfully,

Talking Therapy Provider

Contracts, Health, MH Services

Dear Gloucestershire Health and Care NHS Foundation Trust,

I would be most grateful if you would provide me, under the Freedom of Information Act, answers to the below questions:
1.
For contracts held with external providers of Talking Therapies (formerly IAPT), engaged by you to deliver Talking Therapy services, please confirm:
• The contract start and end dates
• Whether the contract is block-funded, activity-based, or outcome-based
• Whether payment is triggered by completed contacts, completed episodes of care, or other milestones

2.
For each financial year from 2022/23 to 2024/25, please confirm the total expenditure paid to each of the external providers of Talking Therapies (formerly IAPT), engaged by you to deliver Talking Therapy services.

3.
For the same period, please provide:
• The total number of completed clinical contacts delivered by external providers of Talking Therapies (formerly IAPT), engaged by you to deliver Talking Therapy services and/or
• The total number of completed treatment episodes (courses of care), broken down where available by Step 2 and Step 3

4.
If held, please provide any internally reported or calculated figures showing:
• Average cost per completed treatment episode
• Average cost per completed clinical contact
for services delivered by external providers of Talking Therapies (formerly IAPT), engaged by you to deliver Talking Therapy services

5.
Please provide any board papers, performance reports, or internal evaluations which reference:
• Recovery rates, reliable improvement, or waiting-time performance
• In relation to the cost or value for money of services delivered by external providers of Talking Therapies (formerly IAPT), engaged by you to deliver Talking Therapy services

6.
Please confirm whether external providers of Talking Therapies (formerly IAPT), engaged by you to deliver Talking Therapy services, costs were benchmarked against:
• In-house NHS Talking Therapies provision
• Other external providers
and if so, whether the supplier was assessed as lower-cost, comparable, or higher-cost.

7.
Please confirm whether the contract with external providers of Talking Therapies (formerly IAPT), engaged by you to deliver Talking Therapy services, included:
• Minimum activity volumes
• Volume caps
• Break clauses linked to activity or outcomes

8.
Please list any contract variations, extensions, or price uplifts agreed with external providers of Talking Therapies (formerly IAPT), engaged by you to deliver Talking Therapy services, since contract award, including the reason (e.g. demand growth, workforce pressures).

9.
Please confirm whether charges payable to external providers of Talking Therapies (formerly IAPT), engaged by you to deliver Talking Therapy services, included separate line items for:
• Referral processing
• Digital platform access
• Administration or reporting
and if so, the value of these charges.

10.
Please confirm whether the ICB/Trust anticipates:
• Re-tendering
• Extending
• Expanding
NHS Talking Therapies capacity using external providers within the next 24 months.

Yours faithfully,

Guidelines for the Treatment of Patients with Schizophrenia.

Health, Pharmacy

Dear Sir/Madam,
Please find below an FOI request relating to the treatment of patients with schizophrenia.
Question 1: Does Gloucestershire Health and Care NHS Foundation Trust have any local guidelines for the use of antipsychotic medications for the treatment of schizophrenia? Yes/No
If yes, please provide a copy.

Question 2: Does Gloucestershire Health and Care NHS Foundation Trust have any policies for the use of antipsychotic medications in the form of Long acting injectables (LAIs)/Depot injections for any mental health condition? Yes/No
If yes, please provide a copy.

Thank you in advance for your assistance,

Patients Awaiting Initial Assessment-Memory Clinics-Suspected Dementia

Dear Sir/Madam, Under the Freedom of Information Act 2000, I would like to request the following information relating to waiting lists and waiting times for patients awaiting an initial assessment at memory clinics for suspected dementia:

1. Waiting List Size

o The number of patients currently on the waiting list for an initial memory clinic assessment for suspected dementia, as of the most recent available date.

2. Waiting Times

o The average waiting time (in weeks and/or days) from referral to first assessment at your memory clinic for suspected dementia for the most recent reporting period.
o The median waiting time (if available).
o The range of waiting times (shortest and longest) for patients currently on the waiting list.

3. Historical Data

o The waiting list size and average waiting time for the same service for each quarter over the last 12 months (e.g., Q1, Q2, Q3, Q4).

4. Referral and Assessment Source Data

o The number of referrals received in the last 12 months for memory clinic assessments for suspected dementia.
o The number of patients assessed and discharged from the waiting list in the last 12 months.

Please provide this information in an electronic format (e.g., Excel or CSV) if possible.

If you consider any part of this request to be exempt, please provide reasons for your decision, including the relevant exemption clauses.

If the full information is not available, please provide what you do hold and advise how much of the requested information you are unable to supply.

I look forward to your response within 20 working days, as required under the Act.

Yours faithfully,

ASD and ADHD services for children, young people, and adult

Good Morning,

We have recently been awarded NHS Standard Contracts to deliver ASD and ADHD services for children, young people, and adults, including diagnostic assessments and ongoing treatment where appropriate, such as medication and psychoeducation.

As a result, we’re now beginning to receive Right to Choose referrals from patients registered with GP practices in your area.

We are trying to gather as much information as possible to be proactive within our service.

We are formally asking your assistance by providing us with answers to our questions below.

1 Child ASD assessment

a) How many patients are on your waiting list today?
b) What is the longest waiting time for patients on your waiting list?
c) What is the average waiting time for patients on your waiting list?

2 Child ADHD assessment

a) How many patients are on your waiting list today?
b) What is the longest waiting time for patients on your waiting list?
c) What is the average waiting time for patients on your waiting list?

3 Adult ASD assessment

a) How many patients are on your waiting list today?
b) What is the longest waiting time for patients on your waiting list?
c) What is the average waiting time for patients on your waiting list?

4 Adult ADHD assessment

a) How many patients are on your waiting list today?
b) What is the longest waiting time for patients on your waiting list?
c) What is the average waiting time for patients on your waiting list?

Thanking you in advance for your assistance

with Kind regards

Adult Acute Mental Health Inpatient Beds

Dear Freedom of Information Team,

I am writing to request information under the Freedom of Information Act 2000.

Please provide the information requested below in relation to adult acute mental health inpatient beds within your Trust.

For the purposes of this request:

• “Adult” refers to patients aged 18 and over.
• “Adult acute bed” refers to general adult acute mental health inpatient wards and excludes specialist services (e.g. PICU, forensic, CAMHS, learning disability, older adults, rehabilitation, or long-stay wards), unless these are routinely classified by your Trust as adult acute.
• The reporting period is the last 18 months from the date of this request, unless otherwise stated. Information requested

1. Length of stay over 12 months In the last 18 months, how many adult patients detained under the Mental Health Act have had a length of stay exceeding 12 months in an adult acute bed within the Trust? (Please note: the date of admission may fall outside the 18-month reporting period.)

2. Multiple admissions In the last 18 months, how many adult patients have had three or more admissions (i.e. re-admitted two times or more) to an adult acute bed within the Trust?

3. Average length of stay In the last 18 months, what is the average length of stay for adult patients admitted to adult acute wards within the Trust? If possible,

I would appreciate the data provided in aggregate form (e.g. total numbers and averages), and I am happy to receive the response in Excel, CSV, or another standard electronic format.

If any part of this request is exempt under the Act, please provide the reason for the exemption and release any non-exempt information where possible.

Should clarification be required to process this request, please contact me as soon as possible.

I understand that under the Freedom of Information Act 2000, a response should be provided within 20 working days.

Thank you for your time and assistance.

Kind regards

Haemophilia A and B and Von Willebrand Patients

GHNHSFT - Redirect, Health, Pharmacy

Hi FOI team for Gloucestershire Health and Care NHS Foundation Trust,

Under the Freedom of Information (FOI) Act 2000 I would like to obtain the following information:

In the last 3 months (October, November, December 2025), how many haemophilia A and B and von Willebrand patients were treated with the following coagulation factors in your trust and how much volume (IUs or mg) was used?

Best wishes,

Chemsex or Sexualised Drugs

Dear FOI Officer, Under the Freedom of Information Act 2000,

I would like to request the attached information relating to chemsex or sexualised drug use within your Trust.

This is part of a research project being conducted at King’s College London.

I have attached the questions.

Please let me know if you have any questions about the information being requested or need any clarification.

ADHD and Emotional Dysregulation

CAMHS/CYPS, Health, MH Services

Dear FOI Officer,
I am writing to make a request for all the information to which I am entitled under the Freedom of Information Act 2000.

Could you please supply me with the following information concerning the number of people with ADHD and emotional dysregulation in your area as of 2025, if 2025 data is not able to be supplied for any of the questions please supply it for the year 2024.

I would like the above information to be provided to me electronically, preferably in an Excel or Word document. If there are other relevant statistics or links that have not been specified above please also supply those.

If this request is too wide or unclear, I would be grateful if you could contact me, as I understand that under the Act you are required to advise and assist requesters.

I understand that all data must be anonymised, and I am only requesting summary figures rather than any detailed patient reports.

1. The number of patients with ADHD under your trust that also have documented emotional dysregulation, mood disorders, anxiety or self-harm / mood-instability issues recorded.

2. Of those with ADHD, how many have comorbid mental health conditions recorded (e.g., anxiety, depression, low self-esteem, mood disorders)? If possible, please provide the number for each comorbid condition separately.

3. How many ADHD patients were seen by crisis services or home treatment teams in the last 12 months under your trust? (if possible, please also state the reason).

4. How many people with ADHD under your trust are currently in therapy, or waiting for therapy, due to emotional regulation difficulties being recorded as the presenting issue or reason for referral?

5. If possible, please provide the information for each different form of therapy

If any of this information is already in the public domain, please can you direct me to it, with page references and URLs if necessary.

Additionally, if you are only able to answer or hold the information for some of the questions, please supply that still.

I understand that you are required to respond to my request within 20 working days after you receive this letter. I would be grateful if you could confirm in writing that you have received this request.

If you have any queries, please do not hesitate to contact me via email or phone, and I will be happy to clarify what I am asking for. My details are outlined below.

I look forward to hearing from you.

End of Life Care and Unsafe Housing

Hi there,

I am writing to request information under the Freedom of Information Act 2000.

For the most recent three financial years for which data is held, please provide:

The number of patients recorded by the Trust as receiving end of life or palliative care whose housing was documented by Trust staff as

a unsafe or unfit for habitation

b affected by damp, mould, overcrowding or serious disrepair

c temporary accommodation or homelessness

The number of cases where housing conditions were recorded as contributing to

a delayed discharge from hospital

b an inability to provide safe end of life care at home

The number of patients receiving end of life or palliative care who died in hospital where housing conditions were noted as a factor in discharge planning or care decisions.

If question 3 cannot be answered in this form, please instead provide:

The number of patients receiving end of life or palliative care who died in hospital following a delayed discharge, where housing conditions were noted as a contributing factor.

If the information is held in a different format or only partially held, please provide what is available.

If this request exceeds the cost limit, please provide all within the limit.
Thank you for your assistance.

Dementia Inpatients

To whom it may concern,

Please provide me with the following information under the Freedom of Information Act.

How many inpatients with Dementia at your Trust in 2024 and 2025 were accompanied by a healthcare worker or another member of staff when they were sent for scans or tests, where a family member, guardian or other non-member of staff were not present. For context, this doesn’t include porters, it refers to staff members who were there throughout the tests and scans, where a family member, guardian or other non-member of staff was not present. Can you please provide 2024 and 2025 as separate figures.

How many inpatients with Dementia at your Trust in 2024 and 2025 were not accompanied by anyone? For context, this means no family member or guardian were present, nor a healthcare worker or other NHS staff member. Again, porters don’t apply here. Can you please provide 2024 and 2025 as separate figures.

If it is not possible to provide some of the data requested, I would be grateful if you could provide whichever elements of this FOI request are eligible for release.

Therefore, if it is possible to ascertain within the prescribed time limit, without having to provide a fee for further investigations, please respond in electronic form with all the information above to my email address

Mental Health Outsourcing

Health, MH Services, Procurement

Good morning,

Please can you provide me with the below information:

In the last 6 months (June 25- November 25), please confirm if any Mental Health services have been outsourced:

If yes, please confirm:

-The service provided E.G ADHD, Autism etc (please provide breakdown for each service if applicable)

-The name of the company each service was outsourced to

-Is there a contract in place and the length of contract for each service provided (if applicable)

-The value of each service in the last 6 months

Please confirm how this contract was procured E.G Tender, Direct Award etc

Please provide an email and contact name within the outsource provider

Thanks

Mealtime / Dining Room Support – Patients with an Eating Disorder

Eating Disorder, Health

To Whom It May Concern, I am writing to request information under the Freedom of Information Act 2000.

I would be grateful if you could provide copies of any internal guidelines, protocols, policies or standard operating procedures that relate specifically to mealtime/ dining room support in the treatment of eating disorders within your services.

This includes, but is not limited to documents that cover:

– expectations and roles of staff during mealtimes
– levels of supervision and support before, during and after meals or snacks management of meal‑related distress, behaviours or incidents
– use of any structured mealtime programmes or approaches
– nasogastric feeding or the use of oral nutrition supplements If different guidelines are used in different settings,

Please provide all relevant documents. For example, where your organisation has separate or adapted guidance for: inpatient wards day‑hospital or day‑programme services intensive outpatient / intensive community treatment outpatient or community services Similarly.

I would also be grateful if you could provide all protocol versions, if different protocols apply to different age groups, including: adult eating disorder services CAMHS / children and young people’s eating disorder services all‑age or transition services, if applicable

If your organisation does not have written mealtime support guidelines, please kindly let me know.

If you require any clarification in order to process this request, please let me know.

Brain Injuries

CAMHS/CYPS, Health, MH Services

I am writing regarding an FOI data request for the NHS Gloucestershire Health and Care you manage on the care provided for those with traumatic brain injuries. Please find all relevant questions in below and we look forward to receiving the data within 20 working days.


1) How many patients with the primary diagnosis of traumatic brain injury were referred for neurological care following discharge from a rehabilitation unit?
2020 2021 2022 2023 2024
Insert number Insert number Insert number Insert number Insert number

2) What is the average wait time for patients to access neurological care services following referral from rehabilitation?
2020 2021 2022 2023 2024
Under 18 weeks: insert number
Over 18 weeks: insert number Under 18 weeks: insert number
Over 18 weeks: insert number Under 18 weeks: insert number
Over 18 weeks: insert number Under 18 weeks: insert number
Over 18 weeks: insert number Under 18 weeks: insert number
Over 18 weeks: insert number

3) Please provide a list of neurological and rehabilitation services available for patients with traumatic brain injuries within your region

Use of Restraints in Mental Health Services

CAMHS/CYPS, Health

We are submitting a request under the Freedom of Information Act 2000 regarding admissions into mental health inpatient services, disaggregated by demographic characteristics.

1. For the financial year 2023/24, please give the total number of patients disaggregated collectively by disaggregated by gender, ethnicity, and religion or belief, disability status, and sexual orientation admitted into:
a) CAMHS in-patient services*
b) Adult mental health in-patient services

2. For the financial year 2023/24, and disaggregated by gender, ethnicity, and religion or belief, disability status, sexual orientation and restraint type, i.e. prone restraint (also known as face-down restraint), chemical restraint, etc., please give the number of patients who experienced restraint by one or more members of staff in both:
a) adult inpatient mental health services
b) CAMHS inpatient mental health services*

3. For the financial year 2023/24, and disaggregated by gender, ethnicity, and religion or belief, disability status, and sexual orientation and restraint type, i.e. prone restraint (also known as face-down restraint), chemical restraint, etc., please give the number of incidents of restraint experienced by patients in both:
a) adult inpatient mental health services
b) CAMHS inpatient mental health services*

*If your ICB does not provide in-patient CAMHS services please make this clear.

Male Fertility (2)

Dear Gloucestershire Health and Care NHS Foundation Trust,

Under the Freedom of Information Act 2000, I am writing to request information regarding male reproductive health services provided by your Trust. Specifically, we are seeking details on services related to andrology, sperm storage, and male fertility.

Please could you provide answers to the following questions:

1. Does your Trust operate a dedicated andrology or male fertility clinic?
2. Are there any eligibility criteria that limit male patients’ access to fertility treatment?
3. Does your Trust provide NHS-funded sperm storage?
4. Does your Trust offer sperm analysis or testing services for men?
5. Are there specialist male fertility clinicians or andrologists within your fertility teams?
6. Are counselling services offered specifically for male patients regarding fertility issues?
7. If you are unable to provide any counselling services, do you proactively signpost to other peer support or community services?

If possible, please also provide any supporting documentation or policies relevant to the above services.

I would be grateful to receive the answers to these questions in the body of the email, or in a PDF document. If any of the information is not held, please confirm this in your response.

Thank you for your time and assistance.

Yours faithfully,

Male Fertility

Dear Gloucestershire Health and Care NHS Foundation Trust,

Please could you provide answers to the following questions:

If possible, please also provide any supporting documentation or policies relevant to the above services.

I would be grateful to receive the answers to these questions in the body of the email, or in a PDF document. If any of the information is not held, please confirm this in your response.

Thank you for your time and assistance.

Yours faithfully,

Accessible Healthcare for RNID Communities

Health, MH Services, Nursing & Agency Nursing

I am writing to you from the RNID, the national charity supporting the 18 million people in the UK who are deaf, have hearing loss or tinnitus.
Our communities tell us they can sometimes face difficulties can when seeking access to NHS care as a result of failure to meet their communication needs. As you will know, in 2016, NHS England introduced the Accessible Information Standard (AIS) – a document that sets out clear guidance on what must be done to make NHS and publicly funded social care services accessible to people with disability and sensory loss.
I would like to request some information from the NHS Trust that relates to accessible healthcare for RNID’s communities, under the Freedom of Information Act 2000.
1. What proportion of staff employed by the Trust have completed the NHS England e-learning module on the NHS Accessible Information Standard?
2. What proportion of the clinical staff employed by the Trust have completed the NHS England e-learning module on the NHS Accessible Information Standard?
3. Does the Trust offer training on deaf awareness to staff? If so, please specify how the training is delivered.
4. In the last five years, how many NHS complaints has the Trust received which primarily relate to a failure to provide care that is accessible to a person who is deaf or has hearing loss, and/or a failure to provide “reasonable adjustments” during the care of a person who is deaf or has hearing loss?
As you will know, “reasonable adjustments” are a legal requirement under the Equality Act 2010, to make sure health services are accessible to disabled people. Reasonable adjustments in accessing NHS services for a person who is deaf or has hearing loss might include the provision of a BSL interpreter or other communication support professional, facing the patient and not speaking too quickly, or the provision of alternative contact methods to the telephone.
If it is not possible to provide these figures in full without incurring the Act’s Section 12 time/cost limit, please provide any figures you are able to within the limit (e.g. figures for one year, any snapshot reports/audits)

5. In the last five years, what has been the cost of litigation to the NHS Trust as a result of failure to make reasonable adjustments under the Equality Act 2010 to meet the communication needs of patients who are deaf or have hearing loss?
If such payments are processed by NHS Resolution, including where failure to provide reasonable adjustments has been part of a clinical negligence case, please let us know total cost paid as a result of claims against the Trust on this topic.
If it is not possible to provide these figures in full without incurring the Act’s Section 12 time/cost limit, please provide any figures you are able to within the limit.

6. In the last five years, what has been the cost of litigation to the NHS Trust as a result of failure to make reasonable adjustments under the Equality Act 2010 to meet the communication needs of patients with a disability, impairment, or sensory loss (as set out in the NHS Accessible Information Standard)?
If such payments are processed by NHS Resolution, including where failure to provide reasonable adjustments has been part of a clinical negligence case, please let us know total cost paid as a result of claims against the Trust on this topic.

If it is not possible to provide these figures in full without incurring the Act’s Section 12 time/cost limit, please provide any figures you are able to within the limit.

Psychiatry Agency Spend Breakdown

I am writing to request a detailed breakdown of psychiatrist agency spend for the following periods:

• 1st April 2024 – 31st March 2025
• 1st April 2025 – 31st October 2025

Please provide the data in Excel format, with the following details for each month:

• By grade and sub-specialty
• For each hospital
• Split by framework and non-framework agencies

Long Term Sickness 2019 to 2024

Health, HR, Staffing

I would like to make a Freedom of Information Act request for the following information

– How many members of staff employed by your organisation have been on long-term sickness absence in 2019, 2020, 2021, 2022, 2023 and 2024?
and
– At what grades and functions?
and
– How many of these members of staff did not return permanently to work by year?
and
– How many members of staff employed by your organisation who were no longer able to fulfil their current role has your organisation supported to find alternative roles find alternative roles in other parts of the NHS in 2019, 2020, 2021, 2022, 2023 and 2024.

If possible I would welcome this in a CSV file or similar.

If any of the above needs clarification I would be more than happy to provide clarification.

Staff Sickness 2020 to 2025 & Agency Usage

Health, HR, Nursing & Agency Nursing

Under the Freedom of Information Act 2000, I would like to request copies of the following:

1. General sickness absence from 2020-2025:

– The total number of staff sickness absence days taken each year, broken down by year from 2020-2025.

2. Categorisation of sickness absence:

– Does your organisation code sickness absences by specific category or reason (e.g. ‘mental health’, ‘burnout’, ‘flu’, ‘musculoskeletal issues’)?
– If yes, please provide the breakdown for each recorded sickness category for each year in the five-year period (2020-2025).
– If such categorisations have changed over time, please indicate when changes to categories or coding were implemented.

3. Locum and agency staff usage from 2020-2025:

– The total number of locum or agency staff engaged in each year of the five-year period (2020-2025).
– If records permit, please detail the total expenditure on locum or agency staff for each year.
– If possible, please indicate whether the use of locum/agency staff was linked to covering staff sickness absences.

Pulmonary Rehabilitation Services